carbamates has been researched along with Cranial Nerve II Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Slusar, JE | 1 |
| Cairns, EA | 1 |
| Szczesniak, AM | 1 |
| Bradshaw, HB | 1 |
| Di Polo, A | 1 |
| Kelly, ME | 1 |
1 other study available for carbamates and Cranial Nerve II Diseases
| Article | Year |
|---|---|
The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomy.
Topics: Age Factors; Amidohydrolases; Animals; Axotomy; Benzamides; Carbamates; Cell Count; Disease Models, | 2013 |